Recently, AI pharmaceutical enterprisesDP TechnologyHas successively reached cooperation with two listed pharmaceutical companies in China.
August 22,Huadong MedicineHuadong Medicine's wholly-owned subsidiary Hangzhou Zhongmei Huadong Pharmaceutical and DP Technology have officially announcedIn-depth cooperation, Huadong Medicine will fully introduce DP Technology'sUni-FEP Free Energy Perturbation Calculation Tool。The tool is DP Technology's Hermite®The core module of the drug computational design platform, which can be used forEvaluating protein-ligand binding free energy can also be widely applied to predicting ligand selectivity for homologous proteins and protein mutation stability.Prediction and Improvement of ADME/T Properties, providing comprehensive solutions for drug development.August 25,Humanwell HealthcareYichang Humanwell Pharmaceutical, a subsidiary, signs a cooperation agreement with DP Technology. Humanwell Pharmaceutical will deeply utilize DP Technology.Hermite® Drug Calculation Design Platform, including the Uni-FEP module.The report mentioned that hundreds of thousands of calculations from over 50 drug pipeline projects involving 30 clients have shown that Uni-FEP makes the evaluation and decision-making of compounds more efficient, particularly in the molecular evaluation of the same protein target.Can significantly reduce experimental costs by 76% and time costs by 79%。Founded by Peking University Talents, Invested by Hillhouse and Matrix
DP Technology was founded in Beijing in 2018.AI+ScienceStart-up enterprises.Chief Scientific Advisor of the CompanyAcademician Weinan E，Founders Sun Weijie and Zhang Linfeng both graduated fromBeijingUniversity.Based on the "multi-scale modeling + machine learning + high-performance computing" technology, the company has launched the Bohrium® Microscale Scientific Computing Cloud Platform and the Hermite® Drug Computational Design Platform, collaborating with leading customers in the pharmaceuticals, materials, new energy, and other fields.Since 2020, DP Technology has completed multiple rounds of financing, with investments from renowned venture capital institutions and industry funds such as Hillhouse Ventures, Matrix Partners, Source Code Capital, Qiming Venture Partners, and Huawei's Hubble Ventures.The most recent financing was in October 2024.Hundreds of Millions of RMB in Financing, the investor isBeijing Artificial Intelligence Industry Investment Fund and Zhongguancun Science City Company。
